NEOVASTOP is a proprietary angiogenesis inhibition validation method developed by NatureCeuticals. This method comprises of a battery of cutting edge analytical and molecular biology technologies that are used in house to validate anti-angiogenic activity on products developed by NatureCeuticals.

Each batch of herbs harvested from our farms is screened to ensure the presence of active compounds with anti-angiogenic activity at the predetermined cut-off level. Products validated with NEOVASTOP are guaranteed to be anti-angiogenic to attain all the health benefits for this type of pharmacological activity.